Adenoma Clinical Trial - Near Infrared Autofluorescence (NIRAF) Detection

Status Recruiting

Clinical Trial Summary

The goal of this study is to assess whether using PTeye (AiBiomed, Santa Barbara, CA) - a NIRAF detection modality - can improve patient outcomes and reduce healthcare associated costs after parathyroid surgeries. By being able to quickly and definitively locate parathyroid glands while in the operating room, the duration of surgical procedure could be further reduced. In addition, the number of frozen section biopsy and associated costs can be minimized. Furthermore, repeat surgeries as a result of missing a diseased parathyroid gland at the time of the initial parathyroidectomy for hyperparathyroidism could potentially be avoided.

Clinical Trial Description

This is a prospective, single-blinded, randomized study comparing the use of PTeye during parathyroidectomy to usual standard practice. PRIMARY OBJECTIVES: I. Assess the impact of PTeye on intra-operative identification of parathyroid tissues. II. Assess the impact of PTeye on improving efficiency of parathyroid surgeries. III. Assess the impact of PTeye on minimizing risk of post-surgical complications. Participants will be randomized to either the experimental or control arm. The surgeon will first take 5 baseline NIRAF measurements on the thyroid gland (or neck muscles, if thyroid is absent) using the disposable sterile fiber probe that is connected to the PTeye console, as per device functionality requirements. The subsequent step would involve touching the target tissue in the neck with the fiber optic probe, following which the PTeye will indicate to the surgeon if the tissue is likely parathyroid or not. For patients assigned to the control arm, the surgeon will not use the PTeye and will proceed with the parathyroid surgery as usual, while relying solely on her/his surgical experience in identifying the parathyroid glands during the operations. Participants will be follow-ed up for up to 6 months after surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05152927
Study type	Interventional
Source	University of California, San Francisco
Contact	Brandon Yap
Phone	877-827-3222
Email	Brandon.Yap@ucsf.edu
Status	Recruiting
Phase	N/A
Start date	January 10, 2022
Completion date	January 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05551052` - CRC Detection Reliable Assessment With Blood
Recruiting	`NCT02545699` - Prospective Trial to Compare ADR of G-EYE™ Colonoscopy With Standard Colonoscopy	N/A
Completed	`NCT01802008` - Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal Times	N/A
Recruiting	`NCT01211132` - Cap Assisted Colonoscopy for the Detection of Colon Polyps	N/A
Completed	`NCT04287335` - Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China
Not yet recruiting	`NCT06398418` - R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors	Phase 1
Recruiting	`NCT05362344` - Colorectal Cancer Screening in Cystic Fibrosis
Completed	`NCT03268200` - The Effect of Segmental Re-examination of Colon for Adenoma Detection in Colonoscopy	N/A
Recruiting	`NCT04591145` - Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System
Completed	`NCT02978664` - The Impact of Distraction on Adenoma Detection Rate	N/A
Completed	`NCT00018551` - Chemoprevention With Folic Acid	Phase 2
Recruiting	`NCT05594576` - Comparison of the ENDOCUFF VISION® Endoscopy Cap Coupled With GI GENIUS™ Artificial Intelligence Compared to Each Device Alone in Improving Colonic Adenoma Detection Rate During Colonoscopy	N/A
Not yet recruiting	`NCT04135716` - A Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy	N/A
Recruiting	`NCT02552017` - Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities	N/A
Recruiting	`NCT02288962` - Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas	Phase 3
Completed	`NCT02066064` - G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist	N/A
Completed	`NCT01749722` - Safety and Efficacy of the NaviAid™ G-Eye System During Colonoscopy	N/A
Withdrawn	`NCT01546220` - Water Method in Elder Patients With Unsedated Colonoscopy	N/A
Withdrawn	`NCT01546246` - Water Method in Patients With Incomplete Colonoscopy	N/A
Withdrawn	`NCT01546259` - Water Method in Low-body Mass Index (BMI) Female Patients With Unsedated Colonoscopy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms